Immunocore Holdings plc Files 8-K
Ticker: IMCR · Form: 8-K · Filed: Mar 10, 2025 · CIK: 1671927
| Field | Detail |
|---|---|
| Company | Immunocore Holdings PLC (IMCR) |
| Form Type | 8-K |
| Filed Date | Mar 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, financials
Related Tickers: IMCR
TL;DR
IMCR filed an 8-K on 3/10/25, mostly financial docs.
AI Summary
Immunocore Holdings plc filed an 8-K on March 10, 2025, reporting on its activities. The filing primarily concerns financial statements and exhibits, with no specific material events or disclosures detailed in the provided text.
Why It Matters
This filing indicates Immunocore is providing updated financial information or exhibits to the SEC, which is standard procedure for public companies.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for financial statements and exhibits, not indicating any immediate material adverse events.
Key Players & Entities
- Immunocore Holdings plc (company) — Registrant
- March 10, 2025 (date) — Date of Report
- 001-39992 (company) — SEC File Number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Regulation FD Disclosure and Financial Statements and Exhibits.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is March 10, 2025.
What is the SEC file number for Immunocore Holdings plc?
The SEC file number for Immunocore Holdings plc is 001-39992.
Where is Immunocore Holdings plc's principal executive office located?
Immunocore Holdings plc's principal executive office is located at 92 Park Drive, Milton Park, Abingdon, Oxfordshire, United Kingdom, OX14 4RY.
What is the registrant's telephone number?
The registrant's telephone number is +44 1235 438600.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 10, 2025 regarding Immunocore Holdings plc (IMCR).